Morphological and serum hyaluronic acid, laminin and type IV collagen changes in dimethylnitrosamine-induced hepatic fibrosis of rats

World Journal of Gastroenterology

Volumn 11, Issue 48, 2005, Pages 7620-7624

  Li, Chun Hui ^a,c   Piao, Dong Ming ^a   Xu, Wen Xie ^b   Yin, Zheng Ri ^a   Jin, Jing Shun ^a   Shen, Zhe Shi ^a  

^a YANBIAN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c CHENGDE MEDICAL COLLEGE   (China)

Author keywords

DMN; Experimental studies; Hepatic fibrosis; Morphological change; Rat; Serum

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 4; DIMETHYLNITROSAMINE; EOSIN; HEMATOXYLIN; HYALURONIC ACID; LAMININ;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRAL VEIN; CONTROLLED STUDY; CORRELATION ANALYSIS; ELECTRON MICROSCOPY; EMBEDDING; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; LIVER FIBROSIS; LIVER HEMORRHAGE; LIVER NECROSIS; LIVER PARENCHYMA; LIVER STRUCTURE; LIVER VEIN; LIVER WEIGHT; MALE; MYOFIBROBLAST; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN STRUCTURE; RAT; RAT STRAIN; SEROLOGY; STELLATE CELL;

EID: 31644449155     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i48.7620     Document Type: Article

References (27)

1. Du WD, Zhang YE, Zhai WR, Zhou XM. Dynamic changes of type I,III and IV collagen synthesis and distribution of collagen-producing cells in carbon tetrachloride-induced rat liver fibrosis. World J Gastroenterol 1999; 5:397-403
2. Canturk NZ, Canturk Z, Ozden M, Dalcik H, Yardimoglu M, Tulubas F. Protective effect of IGF-1 on experimental liver cirrhosis-induced common bile duct ligation. Hepatogastroenterology 2003; 50: 2061-2066
3. Xu LX, Xie XC, Jin R, Ji ZH, Wu ZZ, Wang ZS. Protein deficiency and muscle damage in carbon tetrachloride induced liver cirrhosis. Food Chem Toxicol 2003; 41: 1789-1797
4. Pan NS, Li ST, Wang Y, Li MF, Han Z. [Therapeutic effect of "anti-hepatic-fibrosis 268" on hepatic fibrosis in rats] Sichuan Da Xue Xue Bao Yi Xue Ban 2004; 35: 528-531
5. Kuroki T, Seki S, Kawakita N, Nakatani K, Hisa T, Kitada T, Sakaguchi H.Expression of antigens related to apoptosis and cell proliferation in chronic nonsuppurative destructive cholangitis in primary biliary cirrhosis. Virchows Arch 1996; 429: 119-129
6. Jia JD. Further systematize and standardize the diagnosis and treatment of liver cirrhosis. Zhonghua Ganzangbing Zazhi 2005; 13: 401-402
7. Jaster R. Molecular regulation of pancreatic stellate cell function. Mol Cancer 2004; 3: 26
8. Breitkopf K, Sawitza I, Gressner AM. Characterization of intracellular pathways leading to coinduction of thrombospondin-1 and TGF-betal expression in rat hepatic stellate cells. Growth Factors 2005; 23: 77-85
9. Tox U, Goeser T. [Therapy of complications of hepatic cirrhosis] Schweiz Rundsch Med Prax 2005; 94: 727-733
10. Jenkins SA, Grandison A, Baxter JN, Day DW, Taylor I, Shields R. A dimethylnitrosamine-induced model of cirrhosis and portal hypertension in the rat. J Hepatol 1985; 1: 489-499
11. Veal N, Auduberteau H, Lemarie C, Oberti F, Cales P. Effects of octreotide on intestinal transit and bacterial translocation in conscious rats with portal hypertension and liver fibrosis. Dig Dis Sci 2001; 46: 2367-2673
12. McCaughan GW, Gorrell MD, Bishop GA, Abbott CA, Shackel NA, McGuinness PH, Levy MT, Sharland AF, Bowen DG, Yu D, Slaitini L, Church WB, Napoli J. Molecular pathogenesis of liver disease: an approach to hepatic inflammation, cirrhosis and liver transplant tolerance. Immunol Rev 2000; 174: 172-191
13. Jung SA, Chung YH, Park NH, Lee SS, Kim JA, Yang SH, Song IH, Lee YS, Suh DJ, Moon IH. Experimental model of hepatic fibrosis following repeated periportal necrosis induced by allylalcohol. Scand J Gastroenterol 2000; 35: 969-975
14. Plummer JL, Ossowicz CJ, Whibley C, Ilsley AH, Hall PD. Influence of intestinal flora on the development of fibrosis and cirrhosis in a rat model. J Gastroenterol Hepatol 2000; 15: 1307-1311
15. Ramalho F. Hepatitis C virus infection and liver steatosis. Antiviral Res 2003; 60: 125-127
16. Lamireau T, Desmouliere A, Bioulac-Sage P, Rosenbaum J. Mechanisms of hepatic fibrogenesis. Arch Pediatr 2002; 9: 392-405
17. Riley TR 3rd, Bhatti AM. Preventive strategies in chronic liver disease: part II. Cirrhosis. Am Fam Physician 2001; 64:1735-1740
18. Murphy F, Arthur M, Iredale J. Developing strategies for liver fibrosis treatment. Expert Opin Investig Drugs 2002; 11: 1575-1585
19. Jezequel AM, Mancini R, Rinaldesi ML, Macarri G, Venturini C, Orlandi F. A morphological study of the early stages of hepatic fibrosis induced by low doses of dimethylnitrosamine in the rat. J Hepatol 1987; 5: 174-187
20. Lee KS, Lee SJ, Park HJ, Chung JP, Han KH, Chon CY, Lee SI, Moon YM. Oxidative stress effect on the activation of hepatic stellate cells. Yonsei Med J 2001; 42. 1-8
21. Yu E, Choe G, Gong G, Lee I. Expression of alpha-smooth muscle actin in liver diseases. J Korean Med Sci 1993; 8: 367-373
22. Tanaka Y, Nouchi T, Yamane M, Irie T, Miyakawa H, Sato C, Marumo F. Phenotypic modulation in lipocytes in experimental liver fibrosis. J Pathol 1991; 164: 273-278
23. Jezequel AM, Mancini R, Rinaldesi ML, Ballardini G, Fallani M, Bianchi F, Orlandi F. Dimethylnitrosamine-induced cirrhosis. Evidence for an immunological mechanism. J Hepatol 1989; 8: 42-52
24. Lee MH, Yoon S, Moon JO. The flavonoid naringenin inhibits dimethylnitrosamine-induced liver damage in rats. Biol Pharm Bull 2004; 27: 72-76
25. Hsu YC, Chiu YT, Lee CY, Lin YL, Huang YT. Increases in fibrosis-related gene transcripts in livers of dimethylnitrosamine-intoxicated rats. J Biomed Sci 2004; 11: 408-417
26. Liang XH, Zheng H. Value of simultaneous determination of serum hyaluronic acid, collagen type IV and the laminin level in diagnosing liver fibrosis. Hunan Yike Daxue Xuebao 2002; 27: 67-68
27. Madden JW, Gertman PM, Peacock EE. Dimethylnitrosamine-induced hepatic cirrhosis:a new canine model of an ancient human disease. Surgery 1970; 68: 260-268